Acrofrontofacionasal dysostosis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1784OMIM:201180Q75.1
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Acrofrontofacionasal dysostosis (AFFND), also known as acrofrontofacionasal dysostosis syndrome, is an extremely rare congenital malformation syndrome characterized by a distinctive combination of craniofacial, nasal, and limb abnormalities. The condition primarily affects the development of the skull, face, nose, and extremities. Key craniofacial features include severe midface hypoplasia, hypertelorism (widely spaced eyes), a broad and bifid nasal tip, cleft lip and/or palate, and brachycephaly (a short, broad skull). Frontal bossing and craniosynostosis (premature fusion of skull sutures) may also be present. Limb anomalies typically involve the hands and feet and can include preaxial polydactyly (extra digits on the thumb or great toe side), brachydactyly (short digits), and syndactyly (fused digits). The condition is apparent at birth due to the visible craniofacial and limb malformations. Intelligence may be normal or variably affected depending on the severity of the craniofacial anomalies. Additional features reported in some patients include short stature and genital anomalies. Only a very small number of cases have been described in the medical literature, making it one of the rarest craniofacial dysostosis syndromes. There is no specific cure or targeted therapy for acrofrontofacionasal dysostosis. Management is supportive and multidisciplinary, typically involving craniofacial surgery to address skull and facial abnormalities, reconstructive surgery for cleft lip and palate, orthopedic interventions for limb anomalies, and ongoing developmental monitoring. A team approach including geneticists, craniofacial surgeons, ENT specialists, and developmental pediatricians is recommended for optimal care.

Also known as:

Clinical phenotype terms— hover any for plain English:

Eyelid colobomaHP:0000625Brushfield spotsHP:0001088Dimple on nasal tipHP:0004132
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Acrofrontofacionasal dysostosis.

View clinical trials →

No actively recruiting trials found for Acrofrontofacionasal dysostosis at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Acrofrontofacionasal dysostosis community →

No specialists are currently listed for Acrofrontofacionasal dysostosis.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Acrofrontofacionasal dysostosis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Acrofrontofacionasal dysostosisForum →

No community posts yet. Be the first to share your experience with Acrofrontofacionasal dysostosis.

Start the conversation →

Latest news about Acrofrontofacionasal dysostosis

No recent news articles for Acrofrontofacionasal dysostosis.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Acrofrontofacionasal dysostosis

What is Acrofrontofacionasal dysostosis?

Acrofrontofacionasal dysostosis (AFFND), also known as acrofrontofacionasal dysostosis syndrome, is an extremely rare congenital malformation syndrome characterized by a distinctive combination of craniofacial, nasal, and limb abnormalities. The condition primarily affects the development of the skull, face, nose, and extremities. Key craniofacial features include severe midface hypoplasia, hypertelorism (widely spaced eyes), a broad and bifid nasal tip, cleft lip and/or palate, and brachycephaly (a short, broad skull). Frontal bossing and craniosynostosis (premature fusion of skull sutures) m

How is Acrofrontofacionasal dysostosis inherited?

Acrofrontofacionasal dysostosis follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Acrofrontofacionasal dysostosis typically begin?

Typical onset of Acrofrontofacionasal dysostosis is neonatal. Age of onset can vary across affected individuals.